EXPANDING THE REACH OF YOUR SLEEP SERVICES TODAY AND TOMORROW
1.877.CLEVEMED (1.877.253.8363)
1.877.CLEVEMED (1.877.253.8363)
SleepView®
SleepViewSM Web Portal
SleepScout™
Sapphire PSG™
Crystal PSG™
CleveMed News Releases
For More Information Contact:
Amy Rickard
Cleveland Medical Devices Inc.
P: 216.791.6720
arickard@clevemed.com
Cleveland, OH - September 17, 2012 - CleveMed, a leader in home sleep testing technologies and services, announced the transition of SleepView™ system sales (Sleepview® Monitor + Web Portal) from Midmark to CleveMed's direct sales and distributors due to the expiration of Midmark's exclusive distribution agreement. Existing and new customers will continue to be serviced and supported by CleveMed, the original developer and manufacturer of the SleepView™ system.
"Midmark continues to be an excellent partner who successfully deployed the SleepView system and services nationally", said Hani Kayyali, CleveMed president. "Home sleep testing is a dynamic, high growth market that requires various business models and sales strategies, which CleveMed is introducing to the marketplace. We are very supportive of our relationship with Midmark and continue to look for their guidance in this area."
SleepView® is ergonomically designed for the patient to monitor sleep apnea by self-administering an easy home sleep test. It's cloud-based data management solution combined with nationwide scoring and interpretation services improve the delivery of care from physician practices while providing access to specialty care.
For more information, please visit www.clevemed.com/sleepview or call 1-877-CleveMed.
Amy Rickard
Cleveland Medical Devices Inc.
P: 216.791.6720
arickard@clevemed.com
CleveMed Announces Transition in Sales and Marketing for its SleepView™ Technologies and Services
Cleveland, OH - September 17, 2012 - CleveMed, a leader in home sleep testing technologies and services, announced the transition of SleepView™ system sales (Sleepview® Monitor + Web Portal) from Midmark to CleveMed's direct sales and distributors due to the expiration of Midmark's exclusive distribution agreement. Existing and new customers will continue to be serviced and supported by CleveMed, the original developer and manufacturer of the SleepView™ system.
"Midmark continues to be an excellent partner who successfully deployed the SleepView system and services nationally", said Hani Kayyali, CleveMed president. "Home sleep testing is a dynamic, high growth market that requires various business models and sales strategies, which CleveMed is introducing to the marketplace. We are very supportive of our relationship with Midmark and continue to look for their guidance in this area."
SleepView® is ergonomically designed for the patient to monitor sleep apnea by self-administering an easy home sleep test. It's cloud-based data management solution combined with nationwide scoring and interpretation services improve the delivery of care from physician practices while providing access to specialty care.
For more information, please visit www.clevemed.com/sleepview or call 1-877-CleveMed.
About CleveMed
SleepView is a registered trademark of and manufactured by Cleveland Medical Devices Inc. of Cleveland, OH. CleveMed is a leader in miniaturized wireless telemetry and physiological monitoring devices and web services. CleveMed has developed a growing range of products that address the needs of those with sleep disorders, including the Crystal Monitor PSG series, Sapphire PSG, SleepScout, DreamPort, SleepView and Web-portal. CleveMed's wireless sleep products allow sleep studies to be conducted remotely, and monitor a wide range of sleep disorder symptoms, while eliminating the need for typically bulky sleep diagnostic equipment. For more information, please visit www.CleveMed.com (Follow us on CleveMed Blogs, twitter, youtube, LinkedIn, and facebook)
©1998-2012 Cleveland Medical Devices Inc.
4415 Euclid Ave (4th Floor), Cleveland OH 44103
Toll-free: 877.CleveMed | 877.253.8363
Phone: 216.791.6720 | Fax: 216.791.6739
24/7 Technical Support (Option 3)
